Mirae Asset Global Investments Co., Ltd. Dexcom Inc Transaction History

Mirae Asset Global Investments Co., Ltd.

  • $20 Billion
  • Q2 2024

A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Dexcom Inc stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 262,672 shares of DXCM stock, worth $17.3 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares
262,672
Previous 814,696 67.76%
Holding current value
$17.3 Million
Previous $113 Million 73.64%
% of portfolio
0.15%
Previous 0.21%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 30, 2024
SELL
$110.31 - $140.45 $60.9 Million - $77.5 Million
-552,024 Reduced 67.76%
262,672 $29.8 Million
Q1 2024

May 01, 2024
SELL
$114.22 - $140.1 $4.11 Million - $5.04 Million
-35,989 Reduced 4.23%
814,696 $113 Million
Q4 2023

Jan 24, 2024
BUY
$75.49 - $124.16 $168,418 - $277,000
2,231 Added 0.26%
850,685 $106 Million
Q3 2023

Oct 26, 2023
BUY
$86.06 - $137.93 $5.78 Million - $9.26 Million
67,146 Added 8.59%
848,454 $79.2 Million
Q2 2023

Aug 10, 2023
SELL
$112.47 - $130.98 $6.41 Million - $7.46 Million
-56,968 Reduced 6.8%
781,308 $100 Million
Q1 2023

May 04, 2023
SELL
$104.0 - $122.92 $17.3 Million - $20.5 Million
-166,766 Reduced 16.59%
838,276 $97.4 Million
Q4 2022

Feb 09, 2023
SELL
$84.98 - $122.67 $5.35 Million - $7.73 Million
-63,005 Reduced 5.9%
1,005,042 $114 Million
Q3 2022

Nov 10, 2022
BUY
$76.35 - $94.18 $1.44 Million - $1.77 Million
18,821 Added 1.79%
1,068,047 $86.3 Million
Q2 2022

Aug 15, 2022
BUY
$67.99 - $132.89 $5.19 Million - $10.1 Million
76,368 Added 7.85%
1,049,226 $78.2 Million
Q2 2022

Jul 26, 2022
BUY
$67.99 - $132.89 $47.7 Million - $93.3 Million
701,859 Added 258.99%
972,858 $72.5 Million
Q1 2022

May 10, 2022
BUY
$94.08 - $130.2 $6.16 Million - $8.53 Million
65,516 Added 31.88%
270,999 $139 Million
Q4 2021

Feb 08, 2022
BUY
$129.87 - $162.82 $1.03 Million - $1.29 Million
7,926 Added 4.01%
205,483 $111 Million
Q3 2021

Nov 15, 2021
BUY
$106.71 - $143.18 $2.61 Million - $3.5 Million
24,467 Added 14.14%
197,557 $108 Million
Q2 2021

Aug 11, 2021
BUY
$80.99 - $107.93 $281,440 - $375,056
3,475 Added 2.05%
173,090 $73.9 Million
Q1 2021

May 13, 2021
BUY
$84.79 - $104.74 $1.75 Million - $2.16 Million
20,654 Added 13.87%
169,615 $61 Million
Q4 2020

Feb 10, 2021
SELL
$78.0 - $104.5 $5.47 Million - $7.33 Million
-70,149 Reduced 32.02%
148,961 $55.1 Million
Q3 2020

Nov 12, 2020
BUY
$95.51 - $112.95 $1.77 Million - $2.1 Million
18,572 Added 9.26%
219,110 $89.3 Million
Q2 2020

Aug 11, 2020
BUY
$62.68 - $105.34 $8.61 Million - $14.5 Million
137,439 Added 217.81%
200,538 $81.3 Million
Q1 2020

May 12, 2020
BUY
$47.79 - $75.63 $388,198 - $614,342
8,123 Added 14.78%
63,099 $17 Million
Q4 2019

Feb 12, 2020
BUY
$36.62 - $57.29 $459,800 - $719,333
12,556 Added 29.6%
54,976 $12 Million
Q3 2019

Nov 12, 2019
SELL
$35.53 - $43.8 $759,027 - $935,699
-21,363 Reduced 33.49%
42,420 $6.33 Million
Q2 2019

Aug 13, 2019
BUY
$27.84 - $38.92 $160,386 - $224,218
5,761 Added 9.93%
63,783 $9.56 Million
Q1 2019

May 13, 2019
SELL
$28.07 - $38.18 $494,424 - $672,502
-17,614 Reduced 23.29%
58,022 $6.91 Million
Q4 2018

Feb 11, 2019
SELL
$26.99 - $37.37 $397,265 - $550,049
-14,719 Reduced 16.29%
75,636 $9.06 Million
Q3 2018

Nov 13, 2018
BUY
$23.35 - $36.72 $2.11 Million - $3.32 Million
90,355 New
90,355 $12.9 Million
Q3 2017

Nov 08, 2017
SELL
$11.36 - $18.98 $282,864 - $472,602
-24,900 Closed
0 $0
Q2 2017

Aug 14, 2017
BUY
N/A
24,900
24,900 $1.82 Million

Others Institutions Holding DXCM

# of Institutions
1,113
Shares Held
365M
Call Options Held
4.1M
Put Options Held
3.65M
View Full List

About DEXCOM INC

DXCM Quotes by TradingView
  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $25.5B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Mirae Asset Global Investments Co., Ltd. Portfolio

Follow Mirae Asset Global Investments Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Investments Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Investments Co., Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email